Comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetoplacental Androgens Excess and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
A condition where the placenta and fetus together produce excess androgens, affecting an XX embryo's development. It is present at birth. Multidisciplinary care helps manage physical and hormonal aspects.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Variable
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
reproductive
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
endocrine
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetoplacental-androgens-excess-C5679876 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may be present at birth from androgen excess. | Genital atypicality is not the defining feature in the supplied description. | Moderate |
| Neurodevelopment | Developmental delay is not established by the source description. | Developmental delay and intellectual disability are associated features. | High |
| Congenital pattern | Primarily a reproductive and hormonal developmental condition. | May involve varied congenital features beyond one organ system. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 when
XX infant with suspected androgen-related atypical genital development
The source centers on fetoplacental androgen excess affecting an XX embryo.
Moderate
Endocrine evaluation is the main clinical question
The condition is categorized as endocrine and reproductive.
Moderate
No chromosomal deletion is suggested by available findings
A negative or unrelated genetic result does not exclude specialist review.
Low
Choose 3q13 Microdeletion Syndrome C2931338 when
Developmental delay with congenital anomalies
These features align with the described microdeletion syndrome.
Moderate
Chromosomal microarray suggests 3q13 material loss
The diagnosis depends on genetic confirmation, not symptoms alone.
High
Multisystem congenital pattern without androgen-driven DSD evidence
The source emphasizes genetic and congenital features.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | 46,XX is part of the named condition. | Sex chromosomes are not the defining abnormality. | Karyotype alone cannot distinguish all causes and needs clinical correlation. |
| Chromosomal microarray | A 3q13 deletion is not required by the description. | Loss of material at 3q13 supports the syndrome. | Genetic results require laboratory and clinician interpretation. |
| Endocrine assessment | Androgen-related evaluation may be relevant. | No specific endocrine abnormality is established here. | Abnormal hormone results are findings, not a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
- Outcome
- Long-term outcome is not established by the source.
- Factors
- Hormonal findings, anatomy, and access to multidisciplinary care may matter.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Outcome is variable and not quantified here.
- Factors
- Developmental profile and congenital features may influence needs.
Time frame: Both are congenital and described as chronic; exact course differs by person.
No mortality, prevalence, or definitive prognosis can be inferred.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormonal and reproductive concerns | Physical and hormonal management may be needed. Not established as the primary issue. Care should be individualized; no treatment dose is implied. |
| Developmental disability | Not established from the supplied source. Intellectual disability may occur. Severity and functional impact vary and are not quantified here. |
| Associated congenital anomalies | Mainly described through sex development. Various congenital features may be present. The exact anomaly pattern is not specified by the source. |
Patient education highlights
- HighDifferent causes
One condition involves androgen exposure in an XX embryo; the other involves missing chromosome 3q13 material.
- HighSpecialist confirmation
Diagnosis should be confirmed by appropriate endocrine or genetic evaluation and clinician interpretation.
- MediumSupportive care
Multidisciplinary care may address physical, hormonal, developmental, and family needs.